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Abstract: miRNAs are important regulators of gene expression that play a key role in many biological
processes. High-throughput techniques allow researchers to discover and characterize large sets of
miRNAs, and enrichment analysis tools are becoming increasingly important in decoding which
miRNAs are implicated in biological processes. Enrichment analysis of miRNA targets is the standard
technique for functional analysis, but this approach carries limitations and bias; alternatives are
currently being proposed, based on direct and curated annotations. In this review, we describe the two
workflows of miRNAs enrichment analysis, based on target gene or miRNA annotations, highlighting
statistical tests, software tools, up-to-date databases, and functional annotations resources in the
study of metazoan miRNAs.
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1. Introduction
Since the discovery of interfering RNAs in 1993 in Caenorhabditis elegans [1] miRNAs have been
continuously characterized by high throughput experimental techniques. miRNAs are non-coding
RNA molecules of ~22 nucleotides that mediate gene silencing by guiding Argonaute (AGO) proteins
to target sites in the 3′ untranslated region (UTR) of mRNAs. Over the past few decades, more than
2000 miRNAs were discovered in humans [2], and their key roles in many development and biological
processes were characterized. miRNAs were also studied in different human diseases and are currently
being pursued in clinical diagnostics and as therapeutic targets [3].
There are several resources that store information about miRNAs. miRBase [4] is one of the
main databases that contain a complete miRNA catalogue with sequence and functional information
covering more than 271 organisms, including 38,589 hairpin precursors and 48,860 mature miRNAs.
Other important miRNAs databases are miRCarta [5] and mirGeneDB [6]. MiRCarta contains miRNA
and precursor data from miRBase, predicted miRNAs from sequencing data though miRMaster [7]
and different publications. mirGeneDB encloses information regarding curated miRNAs across the
metazoan phylum. These are invaluable resources, but important considerations must be kept in mind
related to false positives. For example, many entries in mirBase were reported to be fragments of
other classes of small RNAs including tRNAs, snoRNAs and rRNA. In an effort to discard human
false-positive miRNAs collected in these databases, Alles et al. [2] used small RNA sequencing data from
almost 30,000 samples from different sources, such as miRMaster, The Cancer Genome Atlas (TCGA)
and National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA), to report 2300
true human mature miRNAs, of which 1115 are currently annotated in miRBase. Increasing knowledge
about the role of miRNAs in human diseases also led to the development of dedicated resources, such as
Human miRNADisease Database (HMDD) [8], which contains experimentally validated miRNAs,
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or miRCancer database [9], which incorporates miRNAs mainly associated with different types of
cancers. Similar to HMDD, the Mammal NcRNA-Disease Repository (MNDR) [10] gathers further
mammalian organisms, offering a broader catalogue of associations between diverse ncRNAs and
diseases. The majority of miRNAs databases are dedicated to animals; nevertheless, several are also
dedicated to plants, for example, Plant miRNA Encyclopedia (PmiREN) [11] is a complete, up-to-date
catalogue of plant miRNAs that encompass other existing plant databases.
Next-generation sequencing (NGS) and microarray technologies were widely used in the past
decade to analyze gene mRNAs and miRNAs at the genome level. In the field of transcriptomics,
one common experimental set up is to compare different experimental conditions, i.e., disease versus
healthy samples, to define a list of dysregulated miRNAs, which could range from dozens to hundreds.
A main challenge in this context, and in the characterization of miRNA networks and pathways,
is the drawing of conclusions from these miRNAs lists. This is approached by functional analysis,
also referred to as enrichment or over-representation analysis, which generally, involves deciding
whether miRNAs are significantly enriched in a specific pathway or biological process which may
indicate that the process is associated with the observed phenotype. To perform this analysis, functional
annotations can be retrieved from databases, such as Gene Ontology (GO) [12] or Kyoto Encyclopedia
of Genes and Genomes (KEGG) [13], and statistical tests can be applied to evaluate which terms are
over-represented in the list.
Enrichment analysis is widely used for analyzing gene lists, and functional information and
annotation databases are usually centered on genes. To implement these types of methods for miRNAs,
a common approach is to retrieve their target genes, which are used to infer processes or pathways in
which miRNAs are involved. Alternatively, efforts to centralize the information of a direct association
between miRNAs and biological processes are being carried out. These types of databases allow
researchers to use curated annotations for miRNAs directly for functional analysis, thereby overcoming
some known limitations of indirect miRNA-targets annotations. In this context, Huntley et al. [14,15]
used Gene Ontology to annotate miRNAs, taking advantage of probably the most well-settled biological
ontology in order to directly annotate miRNAs with their functions. They created the initial guidelines,
resulting in 500 mature miRNAs from human, mouse, and rat being associated with nearly 4400 GO
terms so far, of which over 3000 are linked with human miRNAs.
In this work, we provide a detailed overview of the functional analysis pipeline in miRNAs,
including a revision of annotation databases, statistical tests and a comparative analysis of all
available software tools. Further information about quantification methods and downstream miRNAs
analyses should be regarded in other reviews. For example, smallRNA-seq aligners are compared by
Ziemman et al. [16] and four commonly used miRNA-seq analysis tools are comparatively evaluated
with a standard toxicogenomics study design by Bisgin et al. [17].
2. Functional Analysis Workflow in miRNAs
The functional analysis starts with a list of miRNAs (e.g., miRNAs differentially expressed between
two phenotypes) and a set of annotations obtained from two different pipelines (see Figure 1). The most
common approach is based on obtaining all target genes associated with the list of miRNAs, for which
functional gene annotations can be associated, then applying a statistical test to determine their statistical
significance; however, there are some reported drawbacks regarding this strategy. Blaezard et al. [18]
described that this approach results in certain functional categories being preferentially targeted by
miRNAs, regardless of whether those miRNAs are differentially expressed in a biological state or
not. This implies that random sets of miRNAs report significant p-values for certain specific terms.
Equally, Godard and van Eyll [19] proved that the results are not specific and lead to the systematic
identification of highly related biological processes, reporting that random miRNA lists of the same
size as the analyzed signature, result in similar enrichment results and demonstrate bias toward
cancer and cell cycle terms. Although these are important drawbacks, these analyses are still very
useful to derive biological information and are used routinely in published studies. An alternative
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approach is based on using direct and curated annotations of miRNAs obtained through expert-based
annotation from the literature. As mentioned in the introduction, methods following this strategy
gained interest in the last few years fueled by the work of Huntley et al. which integrated miRBase
and Gene Ontology. Additionally, dedicated databases and enrichment tools using direct annotations
are also beginning to be considered, namely, HMDD, MNDR and miRCancer; these databases are
described in the following sections.
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Figure 1. Overview of workflow for functional analysis of miRNAs. Given a list of miRNAs, functional
annotations can be retrieved via direct (in red) or indirect (in blue) schemas. Direct annotations are
obtained from dedicated databases (i.e., MNDR, miRCancer, HMDD, SM2miR), in which functional terms
are directly associated with miRNAs. In the indirect annotations, schema miRNAs are annotated with
terms associated with target genes via gene-centered databases (i.e., Gene Ontology, KEGG, WikiPathways,
HPO). Then, miRNAs are transformed to their target genes using prediction algorithms (TarPMir,
TargetScan, mirTarget, microT-CDS) or experimentally validated targets databases (mirTarBase, TarBase).
Functional terms associated with miRNAs, can be grouped by an MEA approach before statistical analysis.
Different statistical tests can be applied, SEA and MEA use the same tests to evaluate the enrichment of
annotations in the input list with respect to the reference list. Alternatively, threshold-free-based approaches
from GSEA tests can be used to analyze the annotations distribution in the entire ranked list. Finally,
p-values assigned to each annotation can be used to define over-represented and significant annotations.
Once a set of terms associated with miRNAs exists, a statistical test is applied to determine the most
representative annotations in the list. Functional analysis can be classified into three different types [20]
(1) Singular Enrichment Analysis (SEA), in which each functional term is evaluated individually
using different statistical methods, most commonly the hypergeometric distribution (2) Gene Set
Enrichment Analysis (GSEA), which also evaluates independent annotations using a whole set of
genes/miRNAs as ranked by certain criteria, e.g., fold change, and computes an enrichment score using
Kolmogorov-Smirnov statistics; and (3) Modular Enrichment Analysis (MEA), which takes advantages
of the inherent relationship among annotations to define sets of terms that are shared by genes/miRNAs
to evaluate their significance.
3. miRNA-Target Gene Annotation and Resources
Target genes for miRNAs are usually discovered by means of sequence-based prediction algorithms
or through experimental validation. In this section, we describe some popular prediction tools and
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experimentally validated targets databases indicated in Figure 1. We focused on common algorithms
used by functional enrichment tools, but more complete reviews on target predictions algorithms are
published by Riffo-Campos et al. [21], Peterson et al. [22], and Witkos et al. [23].
3.1. miRNA-Target Gene Prediction Methods
miRNA target prediction is mainly performed based on sequence analysis. These type of algorithms
take into account several factors, such as seed pairing and sequence similarity, among miRNA and target
mRNAs [24], accessibility of an mRNA [25] AU content [26], GU wobble in the seed match [27],
3′ compensatory pairing [28], folding energy [26,29,30], and conservation [31]. Notwithstanding,
the binding of a miRNA to its target transcript does not necessarily result in gene expression downregulation.
In fact, most observed miRNA binding events, as revealed by crosslinking immunoprecipitation (CLIP)
analysis, have little functional consequences [32,33]. Thus, in the context of miRNAs functional analysis,
it is important that target prediction algorithms also take into account the effect of target down-regulation
by miRNA with RNA-seq data as a method to confirm real functional associations of miRNAs-targets [29].
Table 1 presents a summary of the described prediction tools.
Table 1. Summary of the miRNA target prediction algorithms described.
Tool Learn AttributesRemark Organisms URL Last Up-Date





TargetScan Score for mammalpredictions
H. sapiens, Mus musculus,
Rattus norvegicus, Pan
troglodytes, Macaca mulatta,
Canis familiaris, M. domestica,
Bos taurus, C. elegans,
Drosophila melanogaster,
Danio rerio, Gallus gallus,
Xenopus tropicalis
http://www.targetscan.org 2015
MiRTarget Functional targets fromRNA-seq
H. sapiens, M. musculus, R.






in CDS and 3′ UTR






TarPmiR [34], one of the most complete prediction algorithms, introduced several new
miRNA-target binding features by applying four different machine learning methods to CLASH
(crossinking, ligation and sequencing of hybrids) data. Apart from the previously mentioned
conventional features, some novel factors introduced in TarPmiR are the consideration of the m/e motif
(how different positions in miRNAs match their corresponding target sites positions), length of the
target mRNA region, length of the largest consecutive pairs, the difference between the number of
paired positions in the seed region and at the miRNA 3′ end, number of paired positions at the miRNA
3′ end, and position of the largest consecutive pairs relative to the miRNA 5′ end and the total number
of paired positions.
Another popular algorithm is TargetScan [32] which is mainly based on seed matching and
searches for the presence of conserved 8mer, 7mer, and 6mer sites of mRNA that match each miRNA.
Sites with mismatches in the seed region but are compensated by conserved 3′ pairing, and centered
sites are also provided. In the last version of TargetScan, predictions of mammal miRNAs are ranked,
based on the predicted efficacy of targeting using cumulative weighted context++ scores of the sites.
Context++ is a machine learning model resulting from a study of 26 features, 14 of which were included
in the algorithm. These features are: (1) 3′UTR target-site abundance, (2) predicted seed-pairing
stability, (3) sRNA position 1, (4) sRNA position 8, (5) site position 8, (6) local AU content, (7) 3′
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supplementary pairing, (8) predicted structural accessibility, (9) minimum distance, (10) probability of
conserved targeting, (11) ORF length, (12) 3′-UTR length, (13) 3′-UTR offset-6mer sites, and (14) open
reading frame (ORF) 8mer sites.
MirTarget [35] is the prediction algorithm that gives rise to MirDB [36], which consists of a support
vector machine model trained using public RNA-seq data and miRNA-target databases to identify
targeting features characteristic of both miRNA binding and target downregulation. Key aspects in this
algorithm include seed conservation, seed match specifically in positions 2–8, base composition in the
regions flanking the seed pairing sites, secondary structure, site accessibility, free energy, and location
of the site within the 3′ UTR. Respectively, MirDB hosts miRNA expression profiles of over 1000 cell
lines and presents target prediction data tailored for specific cell models, as well as predictions of
miRNA functions by integrative analysis of targets and Gene Ontology data.
DIANA microT-CDS [37] is another algorithm for target prediction, which identifies the most
remarkable features extracted from photoactivatable-ribonucleoside-enhanced crosslinking and
immunoprecipitation (PAR-CLIP) datasets via machine learning techniques. This results in an
algorithm with the ability to discover miRNA whose binding location is directly known in both coding
sequences (CDS) and 3′ UTR based on extended seed matching, distance to the nearest end of CDS or
3′ UTR, distance to an adjacent binding site, the free energy of the hybrid, conservation, AU content
and 3′ UTR accessibility.
The combination of different target prediction methods is a common approach to get more
consistent results. For example, Oliveira et al. [38] concluded that the most effective approach was the
union, instead of the intersection, of the results from different algorithms to maximize performance,
and that several true targets were not identified by these tools alone. Tabas-Madrid, D. et al. [39]
proposed two methods to measure the confidence of predicted interactions based on experimentally
validated information. These reassigned new scores and statistical confidences for each predicted
interaction by nine studied algorithms. In this way, they reduce the selection of interactions to a unique
database based on an intuitive score and allow comparing databases between them. Several authors
agree with the union of algorithms methods using different approaches [40–43].
3.2. Validated miRNA-Target Gene Resources
miRTarBase [44] and DIANA-TarBase [45], are two main resources that centralize validated
miRNA-target information. An overview of them is presented in Table 2.
Table 2. Summary of the reviewed databases with experimentally validated miRNA targets genes.
Tool Curation Target-miRNA Organisms URL Last Update










miRTarBase is one of the largest databases of experimentally validated miRNA-target interactions.
The last version, published in 2020, contains almost 480,000 validated interactions extracted from
manual curation from a corpus of 11,021 articles. This database not only includes targets, but also
regulators of miRNAs to investigate the up- and down-regulation of miRNAs. Targets are classified
by the experimental technique used in the validation and whether the evidence is weak or strong.
Reporter assays, Western blotting, and qRT-PCR qualify as strong evidence, whereas high throughput
techniques, e.g., CLIP-seq, microarray, pulsed stable isotope labeling by amino acids in cell culture
(pSILAC), etc., are considered weak evidence. Additionally, disease information from HMDD is
incorporated into this database.
Within the DIANA suite, TarBase reached its eighth version in 2017, and includes over
670,000 unique miRNA-target pairs. Nearly 1200 manually curated publications and more than
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350 high-throughput datasets support miRNAs-target genes evidence in the database. TarBase divides
the targets into low- and high-throughput techniques. Some of the most present methods in the database
are reporter assays, Western blotting, qPCR, proteomics, biotin miRNA tagging, sequencing data and
microarrays, among others. Additionally, disease information from miR2Disease [46] is included.
4. Functional Annotation Resources for miRNAs
Functional annotations for miRNAs can be directly assigned by literature curation or inferred
using information from target genes. In this section, we provide a brief overview of the main biological
information sources used in enrichment analysis for both miRNAs and genes.
4.1. miRNA-Based Annotation Resources
Databases that contain functional information of miRNAs compile annotations obtained via
manual literature searches or text-mining algorithms plus an expert curation process to check evidence
levels. There are many resources focused on associating diseases to miRNAs, while few of them relate
them to concrete biological functions or entities, such as transcription factors, drugs, or epigenetic
modifiers. We briefly describe some of these databases used in miRNAs enrichment tools.
miRCancer is a reference database which includes human miRNA-cancer associations from
empirical evidence; built via text-mining of more than 26,000 PubMed articles, and currently contains
9080 relationships among 57,984 miRNAs and 196 cancers. The algorithm is based on 75 rules,
which represent the common sentence structures typically used to state miRNA expressions in cancers.
All the annotations are confirmed manually after automatic extraction.
HMDD is focused on establishing human miRNA—disease associations evidence-based on manual
curation. Currently, more than 32,281 experimentally supported miRNA—disease links, covering 1102
miRNA genes and 850 diseases from 17,412 papers are contained in the database. All miRNAs included
are standardized to match the miRBase nomenclature and diseases are classified and normalized on
the basis of Disease Ontology [47] and (Medical Subject Headings) MeSH; associations are categorized
in six evidence codes.
In contrast to miRCancer and HMDD, MNDR integrates experimental and predicted ncRNA-
disease associations from manual literature curation and 10 other resources for 11 different mammalian
organisms. More than one million of ncRNA-disease entries, including 6301 miRNAs, 39,880 lncRNAs,
20,256 circRNAs, 10,894 piRNAs and 521 snoRNAs with over 1600 diseases, are stored in the database.
Diseases are mapped to Disease Ontology and MeSH terms. The associations are classified into three
evidence types: Strong experimental evidence, weak experimental evidence and prediction algorithm
and miRNAs following the miRBase nomenclature.
PhenomiR [48] provides data from 542 studies which investigate the deregulation of miRNA
expression in diseases and biological processes as a systematic, manually curated resource. miRNAs are
mapped to miRBase, and diseases are annotated according to the Online Mendelian Inheritance in Man
(OMIM) [49] Morbid Map. SM2miR [50] is another useful resource which contains information about
research on drugs that affect miRNAs expression levels.
4.2. Gene-Based Annotation Resources
Gene Ontology and KEGG are probably the most common databases that store functional
annotations used in enrichment analysis. Although, as mentioned previously, Gene Ontology includes
miRNAs under their terminology, it is still widely used in indirect miRNA enrichment approaches.
Gene Ontology provides a vocabulary for categorizing biological processes, cellular components and
molecular functions. Besides the ontology itself, the consortium also provides annotations for several
organisms, with evidence-based statements relating a specific gene product to specific ontology terms.
The KEGG database is a very popular and well-established resource that originally focused on
metabolic pathways, but currently includes 18 different databases classified into four main categories,
namely, systems, genomics, chemicals and health. KEGG is widely known due to its interactive
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pathways and network maps. In addition to its relevance for basic research, in the last few years,
the database began to move towards biomedicine applications integrating human diseases, drugs and
other health-related substances.
Being part of the GO consortium, Panther (protein analysis through evolutionary relationships) [51]
was born as a classification system of proteins and their genes into families and subfamilies based
on their sequence orthology. This classification, along with a tool suite, allows to performs different
functional analyses based on Gene Ontology and their inherent pathways annotations. The pathways
are complemented with information from Reactome [52], and their own GOSlim version (a subset
of the GO ontology with broader terms) is available. While Panther covers several organisms,
Reactome only applies to human data and aims to annotate validated information regarding
genes, drugs, small molecules, catalysts and regulators throughout more than 1800 pathways
organized in a multilevel hierarchical network that could be collapsed into 26 super-pathways,
e.g., hemostasis or muscle contraction. Another source of pathway annotation is WikiPathways [53],
which was characterized by a crowdsourcing curation and presents more than 2600 pathways.
This classification also implements different ways to train new users and ensure quality terms and
proper evidence tracking.
Disease to gene databases are also well-established, for example, Online Mendelian Inheritance
in Man (OMIM) or Disease Ontology and Human Phenotype Ontology (HPO) [54] are widely used
resources. OMIM focuses on human genes and genetic disorders and traits, highlighting the nature
of their variations and the resulting phenotypes. Currently, OMIM has over 24,600 entries with
approximately 16,000 genes and 8600 phenotypes. The Disease Ontology includes over 9069 disease
terms which are interconnected semantically with other databases, such as OMIM. Likewise, the Human
Phenotype Ontology provides the most comprehensive normalized vocabulary in order to carry out
deep phenotyping in the rare diseases field. Given the heterogeneity of rare diseases, this ontology
was adopted by many organizations, i.e., database of genomic variation and phenotype in humans
using ensemble resources (DECIPHER) [55] and Orphanet.
Information from these databases can also be used to annotate miRNAs-centered resources by linking
them via target genes. For instance, miRPathDB [56] uses Gene Ontology, KEGG, Reactome and WikiPathways.
5. Tools for miRNA Functional Enrichment Analysis
In this section, we provide a review of popular tools used for miRNA functional enrichment
analysis, focused on annotation sources, available organisms, workflow, bias handling and statistical
methods. Table 3 contains a summary of the revised tools specifying the type of annotation,
functional analysis method, target gene sources, available annotations and supported organisms.
In addition, supplementary material (File S1) contains an overview of results from all the reviewed tools
using a list of 26 dysregulated miRNAs in serum exosomes from glioblastoma (GBM) patients [57].
Table 3. Summary of the revised miRNA functional enrichment analysis tools.








H. sapiens, M. musculus,
R. norvegicus, B. taurus,
















D. melanogaster, D. rerio,
H. sapiens, M. musculus,
R. norvegicus.
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Table 3. Cont.
Tool Annotation/BiasHandling Method Targets Sources of Annotations Organism










H. sapiens, M. musculus.
R. norvegicus, Arabidopsis
thaliana, B. taurus, C.
elegans, D. melanogaster,
D. rerio, G. gallus, S. scrofa




H sapiens, M. musculus, R.
norvegicus, C. elegans, D.
melanogaster, D. rerio



















H. sapiens, M. musculus,
R. norvegicus, D.
melanogaster, C. elegans,
G. gallus, D. rerio.
5.1. MiRNet
MiRNet [72] offers a unique way of exploring the interactome of miRNAs. Its database includes 11
different miRNA resources and allows the use of custom data. The interactome includes miRNAs and
their validated and/or predicted targets, plus, elements like xeno-miRs, transcription factors, epigenetic
modifiers, SNPs, pseudogenes, ncRNAs, diseases, and small compounds. All of this information is
available for 10 different model organisms. To use the application users can introduce any of the
mentioned elements alongside a gene expression data table from mRNA or miRNA experiments.
The analysis will report pairwise tables and networks of connections among miRNAs or genes based
on all the different elements selected.
From the network, a functional SEA can be applied with the hypergeometric test, including
direct and indirect annotations depending on the collection selected. If this is based on genes,
an empirical sampling of the test p-values is incorporated along with annotations from GO, KEGG,
Reactome or Diseases, meanwhile, if miRNAs are chosen no empirical sampling is applied because direct
annotations from TAM are available, allowing over-representation in tissues, diseases, miRNA functions,
miRNA clusters, miRNA families and miRNA transcription factors. This dual implementation is
motivated by bias in the indirect approach of miRNA enrichment. The empirical sampling follows
what is described by Bleazar et al. [18] and the inclusion of direct annotations follows a solution
proposed by Godard and van Eyll [19]. The empirical p-values could be re-estimated with another
1000 permutations by resubmitting the functional analysis, but a limitation is that they can only be
obtained by using the full set of genes in the network and results are only reported if p-values are below
0.001. If the hypergeometric test is applied, no p-value cut-off exists; therefore, all the related terms
are shown. MiRNet is available programmatically via R’s package, web application programming
interface (API) and at https://www.mirnet.ca.
5.2. GeneCodis
GeneCodis [73] is a popular functional enrichment tool first presented in 2007 [74] as one of the
first applications for modular enrichment analysis. It allows enrichment analysis of single annotations,
but its main advantage is the extraction of sets of annotations associated with the same set of genes to
evaluate statistical significance. It currently supports 15 annotation sources for biological processes,
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pathways, regulatory elements and drugs. In the last update, GeneCodis incorporated a functionality of
miRNAs enrichment analysis via indirect annotation for 5 of 15 available organisms. Target genes with
strong evidence were retrieved from the last version of miRTarBase. Additionally, from a list of genes,
transcription factors or CpG sites, this database checks which miRNAs are significatively represented.
Depending on the organism selected, different annotations can be used. In both types of
enrichment analysis, the significance of the co-annotation or individual term is obtained using either
the hypergeometric test or the chi-square tests, and p-values are corrected by false discovery rate (FDR)
or using a permutations-based approach. GeneCodis allows users to customize a background set of
genes or miRNAs; by default, all annotated genes are considered. Two bias corrections are available,
namely, with permutations in concordance with the Blaezard et al. bias solution, and also, in the MEA
methodology, a similar grouping of miRNAs targets in co-occurring annotations was proposed by
Godard and van Eyll. This tool also implements different visualization capabilities to explore the
results beyond standard graphs and tables, such as term clustering that is based on gene sharing by
combining principal component analysis and t-SNE (t-distributed Stochastic Neighbor Embedding).
GeneCodis is available at https://genecodis.genyo.es.
5.3. MiEAA
The miRNA Enrichment Analysis and Annotation tool (miEAA) [75] implements GSEA and SEA
for miRNAs. It consists of a comprehensive database of more than 40 different collections obtained
with direct and indirect annotations of miRNAs. The main sources are 15 databases that allow users
to explore associations with pathways, diseases, miRNA nature and classification, drugs, functions,
cells and tissues, targets, and transcription factors. To avoid bias in miRNA enrichment analysis, a
majority of sources providing direct annotations were collected. The statistical method used in the
SEA is the Fisher’s exact test, whereas, GSEA uses an un-weighted variant of the algorithm which
corresponds to a Kolmogorow-Smirnow test. The static GSEA running sum plots shows a simulated
background distribution computed by randomly permuting the input list 100 times and traversing the
running sum for each random permutation. Furthermore, six different procedures are available for
multiple tests correction.
MiEAA uses a list of precursors or mature miRNAs as input, where the user can select from
the enrichment methodologies. In the case of SEA, a background set can be uploaded, otherwise,
all annotated miRNAs/precursors are used as a reference. To perform GSEA the input must be sorted
by some criterion, such as fold change. Once submitted, the results gather all the categories into
a single table. For the top 100, sorted by p-value, a word cloud and heatmaps of miRNA versus
annotation are created, whereas interactive enrichment graphs are shown for GSEA. MiEAA is available
programmatically via API and at: https://ccb-compute2.cs.uni-saarland.de/mieaa2.
5.4. MIENTURNET
MIENTURNET (miRNA enrichment turned network) [76] was published as a tool to study
miRNA-target interactome. Every miRNA and target gene is extracted from TargetScan and those
experimentally validated from miRTarBase. The six organisms shared between these databases are
included in the tool. Four sources of annotations available for functional analysis performance,
specifically, KEGG, Reactome, WikiPathways, and, for human data only, Disease Ontology. These are
linked to genes, indicating that over-representation analysis is performed over the miRNAs targets
and designating it as an indirect annotation approach.
As input, a list of genes or miRNAs can be used. In both cases, this will trigger an enrichment
analysis of miRNAs or targets, respectively, by querying, TargetScan and miRTarBase simultaneously,
which in turn provide two interactomes of miRNA-gene pairs, one is based on predicted interactions and
the other on validated interactions. Targets can be filtered by the type of evidence for miRTarBase and
two prediction scores, the cumulative weighted context++ and the probability of conserved targeting.
Functional analysis can be performed using all the targets of up to 10 miRNAs from the interactomes.
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The significance of terms is addressed with the hypergeometric test, and p-values are corrected using
Benjamini-Hochberg FDR. As a background, by default, the whole genome is used; otherwise, the input
genes are used. MIENTURNET is available at http://userver.bio.uniroma1.it/apps/mienturnet.
5.5. TAM
TAM [58] is a dedicated human miRNA functional analysis tool whereby, through manual
curation of more than 9000 papers, a database was created to characterize around 1200 distinct miRNAs.
These are associated in a total of 1238 miRNA sets distributed throughout 547 diseases, 158 biological
functions, 166 transcription factors, 6 tissues and 211 clusters and 151 families of miRNAs. Interestingly,
the nomenclatures of disease and functional terms were normalized regarding other well-established
ontologies (ICD-10-CM, Disease Ontology, MeSH, OMIM, HPO and Gene Ontology). Another unique
feature of this tool is that for almost all miRNA-disease associations, miRNAs are classified into
two groups, namely, (1) up-miRNA, i.e., miRNAs that are up-regulated in disease conditions, or exhibit
disease-promoting function according to the phenotype from gene permutation assays, and conversely,
(2) down-miRNA, curated in the same way.
TAM is an example of miRNA functional analysis using exclusively direct annotations. Taking into
consideration the bias regarding the knowledge of miRNAs separate from the direct annotations,
this tool provides an option to mask cancer and non-standard miRNA terms when performing analyses.
TAM offers two types of enrichment processes, a SEA with the hypergeometric test, and notably,
a comparison of query miRNAs signature (up and down-regulated) with the disease-based signatures
stored in the database. TAM is available at http://www.lirmed.com/tam2.
5.6. MiTALOS
MiTALOS [77] is a dedicated functional analysis tool for miRNA in which Preusse et al. integrated
three key aspects. First, from CLIP-seq studies of StarBase [78], they extracted high-quality pairs
miRNA-target, but also considered predicted pairs from TargetScan and miRanda [79]. Second,
they captured tissue-specific gene expression from the latest version of EBI Expression Atlas. Lastly,
they included three major pathway databases: KEGG, WikiPathways and Reactome. As a result,
this tool incorporates the specificity of expression signatures of miRNAs and target transcripts in
different tissues to improve the functional analysis of miRNAs. All miRNA information is relative to
H. sapiens and M. musculus.
The approach of miTALOS is an indirect annotation, but thanks to a dynamic database tissue
filter, the results provide insight and may overcome the described bias. In detail, they establish that
the expression of miRNAs and pathways is tissue-specific, therefore miRNAs, genes and pathways
can be discarded in the face of a functional analysis if they are not expressed in the selected tissue.
Terms significance is obtained via Fisher’s exact test and corrected using the Benjamini-Hochberg
procedure. MiTALOS is available at http://mips.helmholtz-muenchen.de/mitalos.
5.7. MiRSystem
MiRSystem [80] is a dedicated source to perform miRNA functional enrichment analysis.
Its miRNAs database is built from miRBase and allows two species, H. sapiens and M. musculus.
Regarding the functional annotations, five databases are collected: KEGG, Gene Ontology, BioCarta,
Pathway Interaction Database, and Reactome.
This tool uses the indirect annotation approach and miRNAs are transformed to target genes
by combining different prediction algorithms and two experimentally validated databases. A list of
targets is obtained after prediction by a minimum number of algorithms. By default, the experimentally
validated targets are added. The test incorporated is the hypergeometric test which is complemented
by calculating the observed/expected (O/E) ratio (i.e., observed genes divided by expected genes under
a term) and an empirical p-value using a permutations test. Similar to other tools, the calculation
of an empirical p-value is a method to overcome bias. A weighted enrichment analysis also was
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developed, which is a unique method compared to the other tools. If miRNAs are introduced along
with a numeric value, e.g., the expression, the enriched pathways are scored according to the expression
of the associated miRNAs. The weight for one miRNA is calculated by dividing its absolute expression
value by the absolute sum of the expression values of all input miRNAs. Thereafter, the pathway
ranking score is obtained by totaling the weight of its miRNA times its enrichment 2log (p-value).
MiRSystem is available at http://mirsystem.cgm.ntu.edu.tw.
5.8. DIANA miRPath
miRPath [81] is part of the DIANA framework and links miRNAs to Gene Ontology and KEGG.
miRNAs are converted to predicted targets by TargetScan or DIANA microT-CDS and/or experimentally
validated targets stored in DIANA TarBase. These associations are available for seven model organisms.
Before performing enrichment analysis for each introduced miRNA, its predicted targets can
be filtered according to each algorithm’s own score system and then collapsed into a single list
either by the intersection of a minimum number of associated miRNAs or by the union of all targets.
miRPath fits into the indirect annotation category, but it comes with statistical implementations for
bias assessment. To obtain p-values, miRPath can use Fisher’s exact test and the DAVID’s EASE
score [82] optionally, p-values can be corrected via Benjamini-Hochberg’s FDR. These values undergo
permutation testing derived from an adaptation of the sampling algorithm presented by Blaezard et al.,
resulting in empirical p-value. Finally, a method consisting of a meta-analysis statistic was developed
to enable the identification of pathways controlled by multiple miRNAs by examining each one
individually and subsequently combining the result probabilities and test statistics. Additionally,
functional analysis can be performed in the opposite direction, i.e., in the reverse search module,
to discover over-representation of miRNAs from a set of targets of a single GO term or KEGG pathway.
DIANA miRPath is available at: http://snf-515788.vm.okeanos.grnet.gr.
6. Conclusions and Discussion
There are numerous databases for miRNAs that provide various types of data, including predicted
and experimental evidence of miRNA and target gene associations. However, the availability of
miRNAs functional information gained importance over the last few years as an essential step to
interpret high-throughput experiments and decipher the biological processes in which they are involved.
In this context, several miRNA enrichment analysis tools were recently introduced, and are becoming
very useful resources in miRNA research. These tools can combine both miRNA target genes plus
gene-based annotations databases and/or direct miRNA functional annotations databases.
Initially, miRNAs functional analysis methods were based on SEA using target genes information,
but different efforts are being realized to provide high-quality direct annotations for miRNAs. In the
indirect approach, it is important to use well-validated target genes, while the use of direct annotations,
miRNA-based databases, requires a well-established and normalized vocabulary. In order to decipher
specific pathways and functions, it is essential the specificity of target prediction algorithms. Therefore,
target validation information or integration of other data sources, such as gene expression, is very
convenient in functional analysis. Tools like GeneCodis, use uniquely target genes validated by
miRTarBase offering MEA, but some others stand out because they incorporate direct annotations,
such as TAM. Differently, miEEA implements GSEA and both types of annotations. These varying
implementations, in addition to statistical tests and supported organisms, offer several alternatives to
perform miRNA enrichment analysis. It is known that each study requires a different setup, whatsoever,
motivated by the bias in the indirect approach, tools that have miRNAs direct annotations should
be preferred whenever possible. Nonetheless, it could be argued that direct annotations are still
lacking and are not widely implemented in miRNAs functional analysis tools. Thus, if miRNAs direct
annotations do not meet the research specificity level and gene-based annotations are necessary, the bias
handling method in the indirect workflow must be noticed. Empirical sampling is the most common
method to assess the bias, while the clustering of annotations in GeneCodis and the background
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specificity of a selected tissue in tools like MiTalos are less implemented. In the case of TAM, although it
uses direct annotations, an option to mask cancer and unspecific terms are available when the miRNAs
list under study is not related to the pathology.
This review provided an overview of the most widely used resources for miRNA functional
analysis, remarking upon the main features in terms of the type of annotation, statistical test, organism or
enrichment analysis method. We expect this review to be useful in selecting the most appropriate
resource depending on the experimental context.
Supplementary Materials: Available online at http://www.mdpi.com/2218-273X/10/9/1252/s1, File S1: Tables
S1–S9. Tables S1–S8: Results from each tool for a 26 miRNAs signature in glioblastoma patients. Table S9: Table
with tools and URLs not included from mentioned resources.
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